Disease Risk Factor Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biolase Technology, Inc.
Device firm provides share repurchase update
October 17th, 2004
Biolase Technology, Inc., (BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on improving dental procedures, provided an update on its share repurchase program originally announced on July 19, 2004, and subsequently expanded to a total of 2.0 million shares on August 9, 2004. As of August 31, 2004, the company had repurchased 1,477,000 shares. Timing of repurchases and exact number of shares of common stock to be purchased in the future will depend upon prevailing market conditions and other factors. Federico Pignatelli, Biolase's chairman commented, "We believe that our shares continue to...
Source: Disease Risk Factor Week (2004-10-17)
|
